Dexcom | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 49.06B 9.04B 2025-03
Align Technology USD 3.79B 57.74M 2025-03
AtriCure USD 454.62M 6.35M 2025-03
Avanos Medical USD 839.4M 10.9M 2025-03
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Cooper Companies USD 8.13B 44.1M 2025-01
Dexcom USD 2.27B 164M 2025-03
Edwards Lifesciences USD 10B 452.8M 2024-12
Globus Medical USD 4.09B 89.26M 2025-03
Hologic USD 4.62B 154.6M 2025-03
Insulet USD 1.33B 119.1M 2025-03
Integra LifeSciences USD 1.52B 21.14M 2025-03
J&J USD 78.11B 6.62B 2025-03
Masimo USD 946.4M 105.5M 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merit Medical Systems USD 1.43B 49.06M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Solventum Corp 3.26B 303M 2025-03
Stryker USD 20.93B 296M 2025-03
Tandem Diabetes Care USD 155.29M 107.81M 2025-03
Teleflex USD 4.1B 182.98M 2025-03
West Pharmaceutical Services USD 2.68B 800K 2025-03
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Dexcom Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.